Download PDF

Other users also viewed these articles

Antibiotic consumption, genetic risk and incidence of metabolic dysfunction-associated steatotic liver disease: a prospective cohort study Ziming Zheng; Yumei Huang; Jijuan Zhang; Jinchi Xie; An Pan; Yunfei Liao; Yu Zhang;
10.1016/j.aohep.2025.102136
Outcomes of repeat conventional transarterial chemoembolization in patients with liver metastases Kamyar Ghabili; Austin-Marley Windham-Herman; Menelaos Konstantinidis; Nikitha Murali; Tabea Borde; Lucas C. Adam; Fabian Laage-Gaupp; MingDe Lin; Julius Chapiro; Christos Georgiades; Nariman Nezami;
10.1016/j.aohep.2024.101529
The Janus of a disease: Diabetes and metabolic dysfunction-associated fatty liver disease Francisco Barrera; Javier Uribe; Nixa Olvares; Paula Huerta; Daniel Cabrera; Manuel Romero-Gómez;
Ann Hepatol. 2024;29: